TABLE 2

Glycemic thresholds of response of counterregulatory hormones, onset of deterioration of brain function, and initiation of symptoms

Glycemic thresholds (mg/dl)P value
DetemirHuman insulin
C-peptide78 ± 9.583 ± 7.60.316
Glucagon64 ± 6.866 ± 7.70.586
Adrenaline62.5 ± 3.964 ± 3.40.339
Noradrenaline54 ± 4.955 ± 5.60.138
Growth hormone61 ± 8.463 ± 8.50.600
Cortisol57 ± 5.955 ± 7.60.531
Pancreatic polypetide57 ± 6.656 ± 10.10.823
Autonomic symptoms55 ± 8.657 ± 7.40.892
    Adrenergic51 ± 7.756 ± 7.80.029
    Colinergic54 ± 9.253 ± 9.20.798
Neuroglicopenic symptoms49 ± 6.647 ± 4.50.432
Cognitive dysfunction51 ± 8.147 ± 3.60.031
  • Data are means ± SD.